Cargando…
Serum PON1 as a biomarker for the estimation of microvascular invasion in hepatocellular carcinoma
BACKGROUND: Microvascular invasion (MVI) is considered as one of the most powerful prognostic factors in hepatocellular carcinoma (HCC). Currently, it could only be diagnosed by post-operative histological examination. This study aimed to assess the diagnostic value of serum paraoxonase 1 (PON1) for...
Autores principales: | Ding, Guang-Yu, Zhu, Xiao-Dong, Ji, Yuan, Shi, Guo-Ming, Shen, Ying-Hao, Zhou, Jian, Fan, Jia, Sun, Hui-Chuan, Huang, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154400/ https://www.ncbi.nlm.nih.gov/pubmed/32309351 http://dx.doi.org/10.21037/atm.2020.01.44 |
Ejemplares similares
-
Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B
por: Huang, Cheng, et al.
Publicado: (2017) -
Identification of serologic biomarkers for predicting microvascular invasion in hepatocellular carcinoma
por: Yu, Yuan-Quan, et al.
Publicado: (2016) -
Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion
por: Li, Jiang, et al.
Publicado: (2023) -
Derivation and validation of machine learning models for preoperative estimation of microvascular invasion risk in hepatocellular carcinoma
por: Chen, Zhiqiang, et al.
Publicado: (2023) -
Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease
por: Mackness, Bharti, et al.
Publicado: (2013)